VelaSmooth™ Therapy – FDA Gives Approval for Cellulite Treatment

By WD Staff June 16, 2005 No Comments

Austin, TX – June 16, 2005 – Syneron Medical Ltd. announced earlier this week the US Food & Drug Administration (FDA) 510(k) pre-marketing clearance of the VelaSmooth™ medical device for the temporary reduction in the appearance of cellulite.  VelaSmooth™ offers a non-surgical, no downtime alternative for patients wishing to treat the appearance of cellulite.

The innovative VelaSmooth™ treatment combines radiofrequency waves, a laser, and a mechanical massage to break up the fat and mobilize the water from tissues to safely and effectively re-contour the skin’s surface, specifically where problem areas of cellulite occur. In addition to the 510(k) clearance, the FDA created a new product category for VelaSmooth™.  According to Dr. Amir Waldman, head of Clinical and Regulatory Affairs for Syneron, this designation of a new product category “reaffirms how technically innovative this device is for the treatment of cellulite.”

Dr. Gregory Nikolaidis, founder of Westlake Dermatology & Cosmetic Surgery, was one of the first physicians in the United States offering VelaSmooth™ treatments to patients.  Since November, approximately 500 treatments have been performed at the practice.  Dr. Nikolaidis often combines VelaSmooth™ treatments with mesotherapy for even more dramatic results.

Dr. Nikolaidis’ experience and expertise is sought by laser companies like Syneron, and he is currently featured on the Syneron website (

WD Staff

A united group of skin care specialists from Westlake Dermatology & Cosmetic Surgery with contributions from Plastic Surgeons, Dermatologists, Aestheticians, Physician Assistants, Aesthetic Nurses, Marketers and Patient Coordinators.

Comments are closed.